Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease

Abstract excerpt

INTRODUCTION AND AIMS: At present, the treatment for moyamoya disease (MMD) primarily consists of combined direct and indirect bypass surgery. Nevertheless, more than half of indirect bypass surgeries fail to develop good collaterals from the dura and temporal muscle. This study aimed to investigate whether microRNAs (miRNAs) in cerebrospinal fluid (CSF) could serve as biomarkers for the prediction of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cervical and Thoracic Myelopathy
• Share to Moyamoya disease diagnosis and treatment
• Share to Neurological Disease Mechanisms and Treatments